Discover the detailed record of transactions filed by Lewis William, 董事长兼首席执行官. Director active across 4 companies, notably INSMED Inc. Cumulatively, 81 disclosures have been published. Breakdown: 1 buy · 28 sells. Total volume traded: €8.6m. Activity tracked since 15 May 2021. The latest transaction was disclosed on 9 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Lewis William is Chair and CEO of INSMED Inc and a director of NewAmsterdam Pharma Co N.V. He has made a total of 55 filings. In the most recent filings, he sold a total of 5,188,114 euros, with notable transactions including a sale of 1,317,183.65 euros on May 15, 2026, and another sale of the same amount on the same day. The first filings date back to February 3, 2016, and the most recent continue until June 26, 2026.